Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
Holding SCNI?
Track your performance easily

Scinai Immunotherapeutics (SCNI) Financial Statements

305 Followers

Scinai Immunotherapeutics Financial Overview

Scinai Immunotherapeutics's market cap is currently ―. The company's EPS TTM is $-5.513; its P/E ratio is -0.63; Scinai Immunotherapeutics is scheduled to report earnings on November 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT-$ 3.52M-$ 9.91M$ -9.21M
EBITDA-$ 3.65M-$ 9.91M$ -8.43M
Net Income Common Stockholders-$ 3.52M-$ 3.75M$ -12.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.87M$ 10.93M$ 14.21M$ 29.44M$ 39.50M
Total Assets$ 17.47M$ 23.29M$ 27.07M$ 74.72M$ 85.57M
Total Debt$ 20.56M$ 23.28M$ 21.54M$ 62.02M$ 77.05M
Net Debt$ 15.69M$ 12.35M$ 7.33M$ 32.58M$ 37.55M
Total Liabilities$ 22.04M$ 28.10M$ 28.83M$ 65.36M$ 81.10M
Stockholders Equity$ -4.57M$ -4.81M$ -1.76M$ 9.36M$ 4.47M
Cash Flow-
Free Cash Flow-$ -3.07M--$ -10.45M
Operating Cash Flow-$ -3.07M--$ -10.41M
Investing Cash Flow-$ -6.00K--$ -84.00K
Financing Cash Flow----$ -468.00K
Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History

Scinai Immunotherapeutics Debt to Assets

Scinai Immunotherapeutics Cash Flow

Scinai Immunotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis